Loading…

Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study

Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridiza...

Full description

Saved in:
Bibliographic Details
Published in:Cells (Basel, Switzerland) Switzerland), 2021-10, Vol.10 (10), p.2695
Main Authors: Corallo, Diana, Zanon, Carlo, Pantile, Marcella, Tonini, Gian Paolo, Zin, Angelica, Francescato, Samuela, Rossi, Bartolomeo, Trevisson, Eva, Pinato, Claudia, Monferrer, Ezequiel, Noguera, Rosa, Aliño, Salvador F, Herrero, Maria Jose, Biffi, Alessandra, Viscardi, Elisabetta, Aveic, Sanja
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3
cites cdi_FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3
container_end_page
container_issue 10
container_start_page 2695
container_title Cells (Basel, Switzerland)
container_volume 10
creator Corallo, Diana
Zanon, Carlo
Pantile, Marcella
Tonini, Gian Paolo
Zin, Angelica
Francescato, Samuela
Rossi, Bartolomeo
Trevisson, Eva
Pinato, Claudia
Monferrer, Ezequiel
Noguera, Rosa
Aliño, Salvador F
Herrero, Maria Jose
Biffi, Alessandra
Viscardi, Elisabetta
Aveic, Sanja
description Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridization (aCGH), whole-exome sequencing (WES), and pharmacogenetics approaches, respectively, have identified relevant copy number alterations (CNAs), single nucleotide variants (SNVs), and polymorphisms (SNPs) that were then combined into an integrated analysis. Spontaneously formed 3D tumoroids obtained from the recurrent mass have also been characterized. The results prove the power of combining CNAs, SNVs, and SNPs analyses to assess clonal evolution during the disease progression by evidencing multiple clones at disease onset and dynamic genomic alterations during therapy administration. The proposed molecular and cytogenetic integrated analysis empowers the disease follow-up and the prediction of tumor recurrence.
doi_str_mv 10.3390/cells10102695
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_cea41b196d8a41d29832e914c9c1ba55</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_cea41b196d8a41d29832e914c9c1ba55</doaj_id><sourcerecordid>2584783021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3</originalsourceid><addsrcrecordid>eNpdkkFr3DAQRk1paUKaY69F0EsvTiRLsqUeCsuyTRZCe0hDj2IsjV0vXimV5IX993G6SchWFw3S4zHDN0XxkdELzjW9tDiOiVFGq1rLN8VpRRteCkH121f1SXGe0obOR7GaUfm-OOGiVrJuxGmBa5-xj5DRkeXV9eXv1S1ZeBj3CRNZuB14i-TOO4wpg3eD70noyKLvI6Y07JD8wCmGdoSUwxbIahfGKQ_BfyULsoSE5DZPbv-heNfBmPD86T4r7r6vfi2vy5ufV-vl4qa0QrFcCgAnOmgdbZzk81Cuwk5Zq4BR6KqGKcY1Cs47qbhQ4CSzTAmqGgRqHfKzYn3wugAbcx-HLcS9CTCYfw8h9gZiHuyIxiII1jJdOzUXrtKKV6iZsNqyFqScXd8Orvup3aKz6HOE8Uh6_OOHP6YPO6MkF5rVs-DLkyCGvxOmbLZDekwMPIYpmUoq0ah5TDajn_9DN2GKcwwHitdCN9VMlQfKxpBSxO6lGUbN4z6Yo32Y-U-vJ3ihn9PnDzZcsVM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2584364972</pqid></control><display><type>article</type><title>Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Corallo, Diana ; Zanon, Carlo ; Pantile, Marcella ; Tonini, Gian Paolo ; Zin, Angelica ; Francescato, Samuela ; Rossi, Bartolomeo ; Trevisson, Eva ; Pinato, Claudia ; Monferrer, Ezequiel ; Noguera, Rosa ; Aliño, Salvador F ; Herrero, Maria Jose ; Biffi, Alessandra ; Viscardi, Elisabetta ; Aveic, Sanja</creator><creatorcontrib>Corallo, Diana ; Zanon, Carlo ; Pantile, Marcella ; Tonini, Gian Paolo ; Zin, Angelica ; Francescato, Samuela ; Rossi, Bartolomeo ; Trevisson, Eva ; Pinato, Claudia ; Monferrer, Ezequiel ; Noguera, Rosa ; Aliño, Salvador F ; Herrero, Maria Jose ; Biffi, Alessandra ; Viscardi, Elisabetta ; Aveic, Sanja</creatorcontrib><description>Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridization (aCGH), whole-exome sequencing (WES), and pharmacogenetics approaches, respectively, have identified relevant copy number alterations (CNAs), single nucleotide variants (SNVs), and polymorphisms (SNPs) that were then combined into an integrated analysis. Spontaneously formed 3D tumoroids obtained from the recurrent mass have also been characterized. The results prove the power of combining CNAs, SNVs, and SNPs analyses to assess clonal evolution during the disease progression by evidencing multiple clones at disease onset and dynamic genomic alterations during therapy administration. The proposed molecular and cytogenetic integrated analysis empowers the disease follow-up and the prediction of tumor recurrence.</description><identifier>ISSN: 2073-4409</identifier><identifier>EISSN: 2073-4409</identifier><identifier>DOI: 10.3390/cells10102695</identifier><identifier>PMID: 34685674</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>3D tumoroids ; array CGH ; Case Report ; Case studies ; Child, Preschool ; Chromosomes ; clonal evolution ; Comparative Genomic Hybridization ; Copy number ; Cytogenetics ; Disease Progression ; Drug Resistance, Neoplasm - genetics ; Evolution ; Exome Sequencing ; Fatal Outcome ; Genes ; Genomes ; Genomics ; Humans ; Hybridization ; Immunophenotyping ; Malignancy ; Medical prognosis ; Mutation ; Neuroblastoma ; Neuroblastoma - genetics ; Patients ; Pharmacogenetics ; Polymorphism, Single Nucleotide - genetics ; recurrent tumor ; Single-nucleotide polymorphism ; Software ; Tumors ; whole exome sequencing</subject><ispartof>Cells (Basel, Switzerland), 2021-10, Vol.10 (10), p.2695</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3</citedby><cites>FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3</cites><orcidid>0000-0002-7104-273X ; 0000-0002-6042-4185 ; 0000-0002-3886-4360 ; 0000-0003-4546-7459 ; 0000-0002-5380-6265</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2584364972/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2584364972?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34685674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Corallo, Diana</creatorcontrib><creatorcontrib>Zanon, Carlo</creatorcontrib><creatorcontrib>Pantile, Marcella</creatorcontrib><creatorcontrib>Tonini, Gian Paolo</creatorcontrib><creatorcontrib>Zin, Angelica</creatorcontrib><creatorcontrib>Francescato, Samuela</creatorcontrib><creatorcontrib>Rossi, Bartolomeo</creatorcontrib><creatorcontrib>Trevisson, Eva</creatorcontrib><creatorcontrib>Pinato, Claudia</creatorcontrib><creatorcontrib>Monferrer, Ezequiel</creatorcontrib><creatorcontrib>Noguera, Rosa</creatorcontrib><creatorcontrib>Aliño, Salvador F</creatorcontrib><creatorcontrib>Herrero, Maria Jose</creatorcontrib><creatorcontrib>Biffi, Alessandra</creatorcontrib><creatorcontrib>Viscardi, Elisabetta</creatorcontrib><creatorcontrib>Aveic, Sanja</creatorcontrib><title>Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study</title><title>Cells (Basel, Switzerland)</title><addtitle>Cells</addtitle><description>Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridization (aCGH), whole-exome sequencing (WES), and pharmacogenetics approaches, respectively, have identified relevant copy number alterations (CNAs), single nucleotide variants (SNVs), and polymorphisms (SNPs) that were then combined into an integrated analysis. Spontaneously formed 3D tumoroids obtained from the recurrent mass have also been characterized. The results prove the power of combining CNAs, SNVs, and SNPs analyses to assess clonal evolution during the disease progression by evidencing multiple clones at disease onset and dynamic genomic alterations during therapy administration. The proposed molecular and cytogenetic integrated analysis empowers the disease follow-up and the prediction of tumor recurrence.</description><subject>3D tumoroids</subject><subject>array CGH</subject><subject>Case Report</subject><subject>Case studies</subject><subject>Child, Preschool</subject><subject>Chromosomes</subject><subject>clonal evolution</subject><subject>Comparative Genomic Hybridization</subject><subject>Copy number</subject><subject>Cytogenetics</subject><subject>Disease Progression</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Evolution</subject><subject>Exome Sequencing</subject><subject>Fatal Outcome</subject><subject>Genes</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Humans</subject><subject>Hybridization</subject><subject>Immunophenotyping</subject><subject>Malignancy</subject><subject>Medical prognosis</subject><subject>Mutation</subject><subject>Neuroblastoma</subject><subject>Neuroblastoma - genetics</subject><subject>Patients</subject><subject>Pharmacogenetics</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>recurrent tumor</subject><subject>Single-nucleotide polymorphism</subject><subject>Software</subject><subject>Tumors</subject><subject>whole exome sequencing</subject><issn>2073-4409</issn><issn>2073-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkkFr3DAQRk1paUKaY69F0EsvTiRLsqUeCsuyTRZCe0hDj2IsjV0vXimV5IX993G6SchWFw3S4zHDN0XxkdELzjW9tDiOiVFGq1rLN8VpRRteCkH121f1SXGe0obOR7GaUfm-OOGiVrJuxGmBa5-xj5DRkeXV9eXv1S1ZeBj3CRNZuB14i-TOO4wpg3eD70noyKLvI6Y07JD8wCmGdoSUwxbIahfGKQ_BfyULsoSE5DZPbv-heNfBmPD86T4r7r6vfi2vy5ufV-vl4qa0QrFcCgAnOmgdbZzk81Cuwk5Zq4BR6KqGKcY1Cs47qbhQ4CSzTAmqGgRqHfKzYn3wugAbcx-HLcS9CTCYfw8h9gZiHuyIxiII1jJdOzUXrtKKV6iZsNqyFqScXd8Orvup3aKz6HOE8Uh6_OOHP6YPO6MkF5rVs-DLkyCGvxOmbLZDekwMPIYpmUoq0ah5TDajn_9DN2GKcwwHitdCN9VMlQfKxpBSxO6lGUbN4z6Yo32Y-U-vJ3ihn9PnDzZcsVM</recordid><startdate>20211009</startdate><enddate>20211009</enddate><creator>Corallo, Diana</creator><creator>Zanon, Carlo</creator><creator>Pantile, Marcella</creator><creator>Tonini, Gian Paolo</creator><creator>Zin, Angelica</creator><creator>Francescato, Samuela</creator><creator>Rossi, Bartolomeo</creator><creator>Trevisson, Eva</creator><creator>Pinato, Claudia</creator><creator>Monferrer, Ezequiel</creator><creator>Noguera, Rosa</creator><creator>Aliño, Salvador F</creator><creator>Herrero, Maria Jose</creator><creator>Biffi, Alessandra</creator><creator>Viscardi, Elisabetta</creator><creator>Aveic, Sanja</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7104-273X</orcidid><orcidid>https://orcid.org/0000-0002-6042-4185</orcidid><orcidid>https://orcid.org/0000-0002-3886-4360</orcidid><orcidid>https://orcid.org/0000-0003-4546-7459</orcidid><orcidid>https://orcid.org/0000-0002-5380-6265</orcidid></search><sort><creationdate>20211009</creationdate><title>Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study</title><author>Corallo, Diana ; Zanon, Carlo ; Pantile, Marcella ; Tonini, Gian Paolo ; Zin, Angelica ; Francescato, Samuela ; Rossi, Bartolomeo ; Trevisson, Eva ; Pinato, Claudia ; Monferrer, Ezequiel ; Noguera, Rosa ; Aliño, Salvador F ; Herrero, Maria Jose ; Biffi, Alessandra ; Viscardi, Elisabetta ; Aveic, Sanja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>3D tumoroids</topic><topic>array CGH</topic><topic>Case Report</topic><topic>Case studies</topic><topic>Child, Preschool</topic><topic>Chromosomes</topic><topic>clonal evolution</topic><topic>Comparative Genomic Hybridization</topic><topic>Copy number</topic><topic>Cytogenetics</topic><topic>Disease Progression</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Evolution</topic><topic>Exome Sequencing</topic><topic>Fatal Outcome</topic><topic>Genes</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Humans</topic><topic>Hybridization</topic><topic>Immunophenotyping</topic><topic>Malignancy</topic><topic>Medical prognosis</topic><topic>Mutation</topic><topic>Neuroblastoma</topic><topic>Neuroblastoma - genetics</topic><topic>Patients</topic><topic>Pharmacogenetics</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>recurrent tumor</topic><topic>Single-nucleotide polymorphism</topic><topic>Software</topic><topic>Tumors</topic><topic>whole exome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Corallo, Diana</creatorcontrib><creatorcontrib>Zanon, Carlo</creatorcontrib><creatorcontrib>Pantile, Marcella</creatorcontrib><creatorcontrib>Tonini, Gian Paolo</creatorcontrib><creatorcontrib>Zin, Angelica</creatorcontrib><creatorcontrib>Francescato, Samuela</creatorcontrib><creatorcontrib>Rossi, Bartolomeo</creatorcontrib><creatorcontrib>Trevisson, Eva</creatorcontrib><creatorcontrib>Pinato, Claudia</creatorcontrib><creatorcontrib>Monferrer, Ezequiel</creatorcontrib><creatorcontrib>Noguera, Rosa</creatorcontrib><creatorcontrib>Aliño, Salvador F</creatorcontrib><creatorcontrib>Herrero, Maria Jose</creatorcontrib><creatorcontrib>Biffi, Alessandra</creatorcontrib><creatorcontrib>Viscardi, Elisabetta</creatorcontrib><creatorcontrib>Aveic, Sanja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cells (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Corallo, Diana</au><au>Zanon, Carlo</au><au>Pantile, Marcella</au><au>Tonini, Gian Paolo</au><au>Zin, Angelica</au><au>Francescato, Samuela</au><au>Rossi, Bartolomeo</au><au>Trevisson, Eva</au><au>Pinato, Claudia</au><au>Monferrer, Ezequiel</au><au>Noguera, Rosa</au><au>Aliño, Salvador F</au><au>Herrero, Maria Jose</au><au>Biffi, Alessandra</au><au>Viscardi, Elisabetta</au><au>Aveic, Sanja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study</atitle><jtitle>Cells (Basel, Switzerland)</jtitle><addtitle>Cells</addtitle><date>2021-10-09</date><risdate>2021</risdate><volume>10</volume><issue>10</issue><spage>2695</spage><pages>2695-</pages><issn>2073-4409</issn><eissn>2073-4409</eissn><abstract>Neuroblastoma (NB) is the most common extra-cranial malignancy in preschool children. To portray the genetic landscape of an overly aggressive NB leading to a rapid clinical progression of the disease, tumor DNA collected pre- and post-treatment has been analyzed. Array comparative genomic hybridization (aCGH), whole-exome sequencing (WES), and pharmacogenetics approaches, respectively, have identified relevant copy number alterations (CNAs), single nucleotide variants (SNVs), and polymorphisms (SNPs) that were then combined into an integrated analysis. Spontaneously formed 3D tumoroids obtained from the recurrent mass have also been characterized. The results prove the power of combining CNAs, SNVs, and SNPs analyses to assess clonal evolution during the disease progression by evidencing multiple clones at disease onset and dynamic genomic alterations during therapy administration. The proposed molecular and cytogenetic integrated analysis empowers the disease follow-up and the prediction of tumor recurrence.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34685674</pmid><doi>10.3390/cells10102695</doi><orcidid>https://orcid.org/0000-0002-7104-273X</orcidid><orcidid>https://orcid.org/0000-0002-6042-4185</orcidid><orcidid>https://orcid.org/0000-0002-3886-4360</orcidid><orcidid>https://orcid.org/0000-0003-4546-7459</orcidid><orcidid>https://orcid.org/0000-0002-5380-6265</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2073-4409
ispartof Cells (Basel, Switzerland), 2021-10, Vol.10 (10), p.2695
issn 2073-4409
2073-4409
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_cea41b196d8a41d29832e914c9c1ba55
source Publicly Available Content (ProQuest); PubMed Central
subjects 3D tumoroids
array CGH
Case Report
Case studies
Child, Preschool
Chromosomes
clonal evolution
Comparative Genomic Hybridization
Copy number
Cytogenetics
Disease Progression
Drug Resistance, Neoplasm - genetics
Evolution
Exome Sequencing
Fatal Outcome
Genes
Genomes
Genomics
Humans
Hybridization
Immunophenotyping
Malignancy
Medical prognosis
Mutation
Neuroblastoma
Neuroblastoma - genetics
Patients
Pharmacogenetics
Polymorphism, Single Nucleotide - genetics
recurrent tumor
Single-nucleotide polymorphism
Software
Tumors
whole exome sequencing
title Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A39%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrated%20CGH/WES%20Analyses%20Advance%20Understanding%20of%20Aggressive%20Neuroblastoma%20Evolution:%20A%20Case%20Study&rft.jtitle=Cells%20(Basel,%20Switzerland)&rft.au=Corallo,%20Diana&rft.date=2021-10-09&rft.volume=10&rft.issue=10&rft.spage=2695&rft.pages=2695-&rft.issn=2073-4409&rft.eissn=2073-4409&rft_id=info:doi/10.3390/cells10102695&rft_dat=%3Cproquest_doaj_%3E2584783021%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c481t-4aad4fabd07d53026d2ef8cc8a10af2718139e433f58348ad51c184087ea0cde3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2584364972&rft_id=info:pmid/34685674&rfr_iscdi=true